Drug recall · June 3, 2015
Acarbose Tablets 50 mg a)10 x 10 Unit Dose Tablets per Blister Pack recall
Why: Subpotent Drug: The firm received an out of specification result for Assay (potency was below specification) at the 9 month stability time point.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Acarbose Tablets 50 mg a)10 x 10 Unit Dose Tablets per Blister Pack, b)100 count Bottles, Rx only, Roxane Laboratories, Inc. Columbus, Ohio 43216, NDC a) 0054-0141-20, b) 0054-0141-25
- Lots / codes
a) Lot # 460073A Exp 04/2016 b) Lot # 460073B Exp 04/2016
- Quantity
- a) 575 Blister Packs, b) 12,802 Bottles
- Company
- Boehringer Ingelheim Roxane Inc, Columbus, OH
- Distribution
- Nationwide and Puerto Rico
- Initiated
- April 2, 2015 · Voluntary: Firm initiated
- Classified
- May 27, 2015
- Reported
- June 3, 2015
- Ended
- February 19, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Acarbose
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.